5HS-68510-96002
2 vaccinations
5 coded responses
24 check-ins
5 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 450 / OH
- Registered
- 2021-09-16
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-09-16
Registered in v-safe
-
2021-09-16
Dose 1 — Pfizer-BioNTech
-
2021-09-16
Survey response — day 0, dose 1MedDRA: Paraesthesia — Feeling: Fair · Site: Pain · Chills, Muscle or body achesFree text: Tingling in armMedDRA releases: 2024-11 · check-in free text available
-
2021-09-17
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work or attend schoolAdult check-in
- 2021-09-18
- 2021-09-19
- 2021-09-20
-
2021-09-21
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Headache, Joint pains, Muscle or body achesAdult check-in
- 2021-09-22
- 2021-09-23
- 2021-09-30
- 2021-10-07
-
2021-10-11
Dose 2 — Pfizer-BioNTech
-
2021-10-11
Survey response — day 0, dose 2MedDRA: Nasal congestion — Feeling: Fair · Site: Pain, Redness · Rash, not including the immediate area around the injection site · Be unable to work or attend schoolFree text: Stuffy noseMedDRA releases: 2024-11 · check-in free text available
-
2021-10-12
Survey response — days 1–6 daily, dose 2MedDRA: Respiratory tract congestion — Feeling: Poor · Site: Pain, Redness · Headache, Joint pains, Fatigue or tiredness · Be unable to work or attend schoolFree text: Moderate CongestionMedDRA releases: 2024-11 · check-in free text available
-
2021-10-13
Survey response — days 1–6 daily, dose 2MedDRA: Respiratory tract congestion — Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness, DiarrheaFree text: Moderate congestionMedDRA releases: 2024-11 · check-in free text available
- 2021-10-15
- 2021-10-16
- 2021-10-17
- 2021-10-18
- 2021-10-25
- 2021-11-03
- 2021-11-08
- 2021-11-15
- 2021-11-24
- 2022-01-12
-
2022-04-13
Survey response — 6 months, dose 2MedDRA: Dyspnoea, Headache, Night sweats, Pain, Pyrexia — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Fever Headache Soreness / aches & pains Night sweats Shortened breathMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-09-16 | Pfizer-BioNTech | No |
| 2 | 2021-10-11 | Pfizer-BioNTech | No |
Free text
Release 9 — day 0, dose 1
Systemic reaction (other): Tingling in arm
Release 10 — day 0, dose 2
Systemic reaction (other): Stuffy nose
Release 10 — days 1–6 daily, dose 2
Systemic reaction (other): Moderate Congestion
Systemic reaction (other): Moderate congestion
Release 11 — 6 months, dose 2
Symptoms: Fever Headache Soreness / aches & pains Night sweats Shortened breath
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Dyspnoea | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Night sweats | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SRO | Nasal congestion | · | · | ✓ |
| SRO | Paraesthesia | · | · | ✓ |
| SRO | Respiratory tract congestion | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release